RIFAXIMIN

作品数:55被引量:289H指数:11
导出分析报告
相关领域:医药卫生更多>>
相关作者:任淑萍陈瑞玲更多>>
相关机构:首都医科大学附属北京天坛医院南昌大学更多>>
相关期刊:《国外药讯》《World Journal of Hepatology》《Open Journal of Gastroenterology》《Current Medical Science》更多>>
相关基金:国家自然科学基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 主题=PROBIOTICSx
条 记 录,以下是1-4
视图:
排序:
Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis被引量:12
《World Journal of Gastroenterology》2021年第22期3050-3063,共14页Segundo Moran Marlene López-Sánchez María del Pilar Milke-García Gustavo Rodríguez-Leal 
Supported by the Mexican Institute of Social Security,No.FFIS/IMSS/PROT/G16/1589;National Council for Science and Technology(CONACYT),No.SALUD-2014-C01-233823.
Minimal hepatic encephalopathy(MHE)corresponds to the earliest stage of hepatic encephalopathy(HE).MHE does not present clinically detectable neurological-psychiatric abnormalities but is characterized by imperceptibl...
关键词:Minimal hepatic encephalopathy SARCOPENIA PROBIOTICS Non-absorbable disaccharides Rifaximin L-ornithine-L-aspartate 
Irritable bowel syndrome: A concise review of current treatment concepts被引量:5
《World Journal of Gastroenterology》2014年第27期8796-8806,共11页Geoffrey C Wall Ginelle A Bryant Michelle M Bottenberg Erik D Maki rew R Miesner 
Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders causing patients to seek medical treatment. It is relatively resource intensive and the source of significant morbidity. Recent insig...
关键词:Irritable bowel syndrome PROBIOTICS RIFAXIMIN LUBIPROSTONE Linaclotide Peppermint oil 
Clinical update for the diagnosis and treatment of Clostridium difficile infection被引量:6
《World Journal of Gastrointestinal Pharmacology and Therapeutics》2014年第1期1-26,共26页Edward C Oldfield Ⅳ Edward C Oldfield Ⅲ David A Johnson 
Clostridium difficile infection(CDI)presents a rapidly evolving challenge in the battle against hospitalacquired infections.Recent advances in CDI diagnosis and management include rapid changes in diagnostic approach ...
关键词:CLOSTRIDIUM DIFFICILE Antibiotic-associated DIARRHEA Fidaxomicin RIFAXIMIN FECAL transplantation PROBIOTICS 
Recent and currently emerging medical treatment options for the treatment of alcoholic hepatitis被引量:2
《World Journal of Hepatology》2011年第8期211-214,共4页Gabriel L Reep Roger D Soloway 
Patients with severe alcoholic hepatitis (AH) need to be treated with specific treatment for better outcome.Currently available specific treatment modalities are use of corticosteroids or pentoxifylline.However,the re...
关键词:ALCOHOLIC hepatitis Tumor necrosis factor-α inhibitors INFLIXIMAB ETANERCEPT Antioxidants PROBIOTICS RIFAXIMIN BETAINE Granulocytapheresis 
检索报告 对象比较 聚类工具 使用帮助 返回顶部